Company / R&D per Share
CASTLE BIOSCIENCES INC R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.75
FY2025
5-year range
$1.17 / $2.02
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
#54 of 109
Health Care
What the data says
At $1.75, CASTLE BIOSCIENCES INC's r&d per share ranks #54 of 109 in the Health Care sector. R&D per Share has fluctuated over the past 8 years, ranging from $0.77 in FY2020 to $3.85 in FY2019.
Based on SEC 10-K filings.
1.75 in FY2025 with a 5-year CAGR of +17.7%.
Declined from $2.02 to $1.75 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +17.7%
- 10-Year CAGR
- -
Sector benchmark
#54 of 109 in Health CareTop 50% of 109This company $1.75 Sector average $2.08
▼
-15.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 4.4% year-over-year.
- Ranks #54 out of 109 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.75 | -4.4% |
| FY2024 | $1.83 | -9.5% |
| FY2023 | $2.02 | +19.4% |
| FY2022 | $1.69 | +44.8% |
| FY2021 | $1.17 | +51.0% |
| FY2020 | $0.77 | -79.9% |
| FY2019 | $3.85 | +51.3% |
| FY2018 | $2.55 | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026